Immunoglobulin G Immunosuppression of Multiple Sclerosis: Suppression of All Three Major Lymphocyte Subsets

Richard Tenser, Kathleen A. Hay, Judith A. Aberg

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Six patients with relapsing chronic progressive multiple sclerosis were treated on 2 consecutive days with large amounts of IgG to induce immunosuppression. Peripheral blood lymphocyte subsets were monitored for 5 weeks after IgG treatment to determine immunosuppression. Decreased numbers of B, T, and natural killer lymphocytes were detected after treatment. Lymphocyte numbers were at a nadir 1 week after treatment, but an immunosuppressive effect continued to be present after 5 weeks. Although clinical efficacy was not evident in this brief open trial, the decrease of peripheral lymphocyte numbers and the apparent safety of the procedure warrant further study.

Original languageEnglish (US)
Pages (from-to)417-420
Number of pages4
JournalArchives of Neurology
Volume50
Issue number4
DOIs
StatePublished - Jan 1 1993

Fingerprint

Lymphocyte Subsets
Immunosuppression
Multiple Sclerosis
Immunoglobulin G
Lymphocyte Count
Chronic Progressive Multiple Sclerosis
Immunosuppressive Agents
Therapeutics
Lymphocytes
Safety
Suppression

All Science Journal Classification (ASJC) codes

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

@article{98c727e385f44982a0cd3951f530c830,
title = "Immunoglobulin G Immunosuppression of Multiple Sclerosis: Suppression of All Three Major Lymphocyte Subsets",
abstract = "Six patients with relapsing chronic progressive multiple sclerosis were treated on 2 consecutive days with large amounts of IgG to induce immunosuppression. Peripheral blood lymphocyte subsets were monitored for 5 weeks after IgG treatment to determine immunosuppression. Decreased numbers of B, T, and natural killer lymphocytes were detected after treatment. Lymphocyte numbers were at a nadir 1 week after treatment, but an immunosuppressive effect continued to be present after 5 weeks. Although clinical efficacy was not evident in this brief open trial, the decrease of peripheral lymphocyte numbers and the apparent safety of the procedure warrant further study.",
author = "Richard Tenser and Hay, {Kathleen A.} and Aberg, {Judith A.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1001/archneur.1993.00540040069017",
language = "English (US)",
volume = "50",
pages = "417--420",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "4",

}

Immunoglobulin G Immunosuppression of Multiple Sclerosis : Suppression of All Three Major Lymphocyte Subsets. / Tenser, Richard; Hay, Kathleen A.; Aberg, Judith A.

In: Archives of Neurology, Vol. 50, No. 4, 01.01.1993, p. 417-420.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immunoglobulin G Immunosuppression of Multiple Sclerosis

T2 - Suppression of All Three Major Lymphocyte Subsets

AU - Tenser, Richard

AU - Hay, Kathleen A.

AU - Aberg, Judith A.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Six patients with relapsing chronic progressive multiple sclerosis were treated on 2 consecutive days with large amounts of IgG to induce immunosuppression. Peripheral blood lymphocyte subsets were monitored for 5 weeks after IgG treatment to determine immunosuppression. Decreased numbers of B, T, and natural killer lymphocytes were detected after treatment. Lymphocyte numbers were at a nadir 1 week after treatment, but an immunosuppressive effect continued to be present after 5 weeks. Although clinical efficacy was not evident in this brief open trial, the decrease of peripheral lymphocyte numbers and the apparent safety of the procedure warrant further study.

AB - Six patients with relapsing chronic progressive multiple sclerosis were treated on 2 consecutive days with large amounts of IgG to induce immunosuppression. Peripheral blood lymphocyte subsets were monitored for 5 weeks after IgG treatment to determine immunosuppression. Decreased numbers of B, T, and natural killer lymphocytes were detected after treatment. Lymphocyte numbers were at a nadir 1 week after treatment, but an immunosuppressive effect continued to be present after 5 weeks. Although clinical efficacy was not evident in this brief open trial, the decrease of peripheral lymphocyte numbers and the apparent safety of the procedure warrant further study.

UR - http://www.scopus.com/inward/record.url?scp=0027409418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027409418&partnerID=8YFLogxK

U2 - 10.1001/archneur.1993.00540040069017

DO - 10.1001/archneur.1993.00540040069017

M3 - Article

C2 - 8460964

AN - SCOPUS:0027409418

VL - 50

SP - 417

EP - 420

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 4

ER -